Izotropic Corporation (FRA:1R3)

Market Cap	13.76M
Revenue (ttm)	n/a
Net Income (ttm)	-1.46M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1870
Previous Close	0.2000
Day's Range	0.1870 - 0.1870
52-Week Range	0.0106 - 0.2800
Beta	n/a
RSI	41.51
Earnings Date	Dec 30, 2025

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2016
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1R3

Financial Performance

Financial numbers in CAD